Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Candel Therapeutics, Inc. Common Stock (CADL)

Biological Products, (no Disgnostic Substances)

https://www.candeltx.com

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

117 KENDRICK STREET, SUITE 450
NEEDHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/27/2021

Market Cap

176,787,248

Shares Outstanding

28,920,000

Weighted SO

28,919,810

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

AVTE --.--%

ADAG --.--%

ACRV --.--%

RZLT --.--%

ANTX --.--%

MOLN --.--%

MLYS --.--%

PHVS --.--%

PEPG --.--%

Beta

-0.9440

Last Div

0.0000

Range

0.66-14.3

Chg

0.1300

Avg Vol

589611

Mkt Cap

176787248

Exch

NASDAQ

Country

US

Phone

617 916 5445

DCF Diff

5.0478

DCF

0.4372

Div Yield

0.0000

P/S

99.5424

EV Multiple

-4.9912

P/FV

-16.5091

Div Yield %

0.0000

P/E

-3.2934

PEG

0.0027

Payout

0.0000

Current Ratio

1.6244

Quick Ratio

1.6244

Cash Ratio

1.5329

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

141.3640

CCC

-141.3640

Gross Margin

0.3705

Op Margin

-20.0743

Pretax Margin

-28.1464

Net Margin

-28.1464

Eff Tax Rate

-0.0101

ROA

-1.8874

ROE

-6.2929

ROCE

-2.8547

NI/EBT

1.0000

EBT/EBIT

1.4021

EBIT/Rev

-20.0743

Debt Ratio

0.6745

D/E

-1.7913

LT Debt/Cap

-3.0586

Total Debt/Cap

2.2637

Int Coverage

-429.5422

CF/Debt

-1.7279

Equity Multi

-2.6559

Rec Turnover

0.0000

Pay Turnover

2.5820

Inv Turnover

0.0000

FA Turnover

0.5219

Asset Turnover

0.0671

OCF/Share

-1.0331

FCF/Share

-1.0385

Cash/Share

0.7180

OCF/Sales

-17.3795

FCF/OCF

1.0053

CF Coverage

-1.7279

ST Coverage

-2.9828

CapEx Coverage

-189.3620

Div&CapEx Cov

-189.3620

P/BV

-16.5091

P/B

-16.5091

P/S

99.5424

P/E

-3.2934

P/FCF

-5.6975

P/OCF

-5.3337

P/CF

-5.3337

PEG

0.0027

P/S

99.5424

EV Multiple

-4.9912

P/FV

-16.5091

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 04, 08:00 Candel Therapeutics Presents Preclinical Data from its enLIGHTENâ„¢ Discovery Platform at SITC GlobeNewswire Inc. Nov 04, 08:00 Candel Therapeutics Presents Preclinical Data from its enLIGHTENâ„¢ Discovery Platform at SITC GlobeNewswire Inc. Nov 04, 08:00 Candel Therapeutics Presents Preclinical Data from its enLIGHTENâ„¢ Discovery Platform at SITC

Revenue Product Segmentation